{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:21:03Z","timestamp":1768342863461,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00347-025-02223-9","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:59:12Z","timestamp":1748440752000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pseudoxanthoma elasticum\u00a0\u2013 Neue Therapieans\u00e4tze am Horizont?","Pseudoxanthoma elasticum\u2014Novel therapeutic approaches on the horizon?"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1515-1863","authenticated-orcid":false,"given":"Jonathan","family":"Meinke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Raming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"2223_CR1","first-page":"609","volume":"23","author":"FJ Darrier","year":"1896","unstructured":"Darrier\u00a0FJ (1896) Pseudoxanthoma elasticum. Monatschr Prakt Dermatol 23:609\u2013617","journal-title":"Monatschr Prakt Dermatol"},{"key":"2223_CR2","first-page":"491","volume":"2","author":"D Rigal","year":"1881","unstructured":"Rigal\u00a0D (1881) Observation pour seveir a\u00a0l\u2019histoire de la cheloide diffuse xqnthelasmique. Ann Dermatol Syphilol 2:491\u2013501","journal-title":"Ann Dermatol Syphilol"},{"key":"2223_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1755-3768.1929.tb07934.x","volume":"7","author":"E Gr\u00f6nblad","year":"1929","unstructured":"Gr\u00f6nblad\u00a0E (1929) Angioid Streaks \u2013 Pseudoxanthoma Elasticum. acta Ophthalmol 7:329\u2013329","journal-title":"acta Ophthalmol"},{"key":"2223_CR4","first-page":"689","volume":"31","author":"J Strandberg","year":"1929","unstructured":"Strandberg\u00a0J (1929) Pseudoxanthoma elasticum. Meeting of the Dermatological Society in Stockholm. Zentralbl Haut Geschlechtskrankh 31:689","journal-title":"Zentralbl Haut Geschlechtskrankh"},{"key":"2223_CR5","doi-asserted-by":"crossref","unstructured":"Bergen AAB, Plomp AS, Schuurman EJ et\u00a0al (2000) Mutations in ABCC6 Cause Pseudoxanthoma Elasticum. http:\/\/www.tigr.org","DOI":"10.1038\/76109"},{"issue":"4","key":"2223_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ajmg.a.33329","volume":"152","author":"AS Plomp","year":"2010","unstructured":"Plomp\u00a0AS, Toonstra\u00a0J, Bergen\u00a0AAB, Van Dijk\u00a0MR, De Jong\u00a0PTVM (2010) Proposal for updating the pseudoxanthoma elasticum classification system and a\u00a0review of the clinical findings. Am J Med Genet\u00a0A 152(4):1049\u20131058. https:\/\/doi.org\/10.1002\/ajmg.a.33329","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2223_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22062858","volume":"22","author":"F Bisaccia","year":"2021","unstructured":"Bisaccia\u00a0F, Koshal\u00a0P, Abruzzese\u00a0V, Castiglione Morelli\u00a0MA, Ostuni\u00a0A (2021) Structural and functional characterization of the abcc6 transporter in hepatic cells: Role on pxe, cancer therapy and drug resistance. int J Mol Sci 22(6):1\u201312. https:\/\/doi.org\/10.3390\/ijms22062858","journal-title":"int J Mol Sci"},{"key":"2223_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051893","author":"M Van Gils","year":"2023","unstructured":"Van Gils\u00a0M, Depauw\u00a0J, Coucke\u00a0PJ et\u00a0al (2023) Inorganic Pyrophosphate Plasma Levels Are Decreased in Pseudoxanthoma Elasticum Patients and Heterozygous Carriers but Do Not Correlate with the Genotype or Phenotype. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm12051893","journal-title":"J Clin Med"},{"issue":"7","key":"2223_CR9","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ophtha.2009.11.008","volume":"117","author":"PC Issa","year":"2010","unstructured":"Issa\u00a0PC, Finger\u00a0RP, G\u00f6tting\u00a0C, Hendig\u00a0D, Holz\u00a0FG, Scholl\u00a0HPN (2010) Centrifugal Fundus Abnormalities in Pseudoxanthoma Elasticum. Ophthalmology 117(7):1406\u20131414. https:\/\/doi.org\/10.1016\/j.ophtha.2009.11.008","journal-title":"Ophthalmology"},{"key":"2223_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00014","author":"M Gliem","year":"2013","unstructured":"Gliem\u00a0M, De Zaeytijd\u00a0J, Finger\u00a0RP, Holz\u00a0FG, Leroy\u00a0BP, Issa\u00a0PC (2013) An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2013.00014","journal-title":"Front Genet"},{"key":"2223_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100370","author":"S Wada","year":"2024","unstructured":"Wada\u00a0S, Miyake\u00a0M, Kido\u00a0A et\u00a0al (2024) Epidemiology of Angioid Streaks and Pseudoxanthoma Elasticum (2011\u20132020): A\u00a0Nationwide Population-based Cohort Study. Ophthalmol Sci. https:\/\/doi.org\/10.1016\/j.xops.2023.100370","journal-title":"Ophthalmol Sci"},{"key":"2223_CR12","doi-asserted-by":"crossref","unstructured":"Hess K, Gliem M, Birtel J et\u00a0al (1988) Impaired dark adaptation associated with a diseased bruch membrane in pseudoxanthoma elasticum. http:\/\/journals.lww.com\/retinajournal","DOI":"10.1097\/IAE.0000000000002689"},{"key":"2223_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051358","author":"AK Nigalye","year":"2022","unstructured":"Nigalye\u00a0AK, Hess\u00a0K, Pundlik\u00a0SJ, Jeffrey\u00a0BG, Cukras\u00a0CA, Husain\u00a0D (2022) Dark Adaptation and Its Role in Age-Related Macular Degeneration. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm11051358","journal-title":"J Clin Med"},{"key":"2223_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJO.2024.03.026","author":"K Raming","year":"2024","unstructured":"Raming\u00a0K, Pfau\u00a0M, Herrmann\u00a0P, Holz\u00a0FG, Pfau\u00a0K (2024) Anti-VEGF treatment for secondary neovascularization in pseudoxanthoma elasticum\u2014age of onset, treatment frequency and visual outcome. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/J.AJO.2024.03.026","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2223_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejvs.2022.08.009","volume":"65","author":"MC Verwer","year":"2023","unstructured":"Verwer\u00a0MC, Hazenberg\u00a0CEVB, Spiering\u00a0W, de Borst\u00a0GJ (2023) Peripheral Interventions in Patients with Pseudoxanthoma Elasticum (PXE). Eur J Vasc Endovascular Surg 65(1):142\u2013148. https:\/\/doi.org\/10.1016\/j.ejvs.2022.08.009","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"2223_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.athplu.2023.12.003","volume":"55","author":"IM Harmsen","year":"2024","unstructured":"Harmsen\u00a0IM, Visseren\u00a0FLJ, Kok\u00a0M, de Jong\u00a0PA, Spiering\u00a0W (2024) Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A\u00a0comparative study with population-based reference values and Non-PXE controls. atherosclerosis Plus 55:5\u201311. https:\/\/doi.org\/10.1016\/j.athplu.2023.12.003","journal-title":"atherosclerosis Plus"},{"key":"2223_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121895","author":"MJ Stumpf","year":"2021","unstructured":"Stumpf\u00a0MJ, Schahab\u00a0N, Nickenig\u00a0G, Skowasch\u00a0D, Schaefer\u00a0CA (2021) Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9121895","journal-title":"Biomedicines"},{"issue":"1","key":"2223_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jaad.2019.02.055","volume":"81","author":"S Rose","year":"2019","unstructured":"Rose\u00a0S, On\u00a0SJ, Fuchs\u00a0W et\u00a0al (2019) Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A\u00a0randomized trial. J\u00a0Am Acad Dermatol 81(1):263\u2013265. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.055","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2223_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/J.AJPATH.2012.12.037","volume":"182","author":"Q Li","year":"2013","unstructured":"Li\u00a0Q, Guo\u00a0H, Chou\u00a0DW et\u00a0al (2013) Warfarin accelerates ectopic mineralization in Abcc6(\u2212\/\u2212) mice: clinical relevance to pseudoxanthoma elasticum. Am J Pathol 182(4):1139\u20131150. https:\/\/doi.org\/10.1016\/J.AJPATH.2012.12.037","journal-title":"Am J Pathol"},{"issue":"11","key":"2223_CR20","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.4161\/CC.10.11.15681","volume":"10","author":"C Brampton","year":"2011","unstructured":"Brampton\u00a0C, Yamaguchi\u00a0Y, Vanakker\u00a0O et\u00a0al (2011) Vitamin\u00a0K does not prevent soft tissue mineralization in a\u00a0mouse model of pseudoxanthoma elasticum. Cell Cycle 10(11):1810\u20131820. https:\/\/doi.org\/10.4161\/CC.10.11.15681","journal-title":"Cell Cycle"},{"issue":"4","key":"2223_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4161\/CC.10.4.14862","volume":"10","author":"Q Jiang","year":"2011","unstructured":"Jiang\u00a0Q, Li\u00a0Q, Grand-Pierre\u00a0AE, Schurgers\u00a0LJ, Uitto\u00a0J (2011) Administration of vitamin\u00a0K does not counteract the ectopic mineralization of connective tissues in Abcc6 (\u2212\/\u2212) mice, a\u00a0model for pseudoxanthoma elasticum. Cell Cycle 10(4):701\u2013707. https:\/\/doi.org\/10.4161\/CC.10.4.14862","journal-title":"Cell Cycle"},{"key":"2223_CR22","doi-asserted-by":"crossref","unstructured":"Drake MT, Clarke BL, Bisphosphonates KS (2008) Mechanism of Action and Role in. Clin Pract","DOI":"10.4065\/83.9.1032"},{"issue":"4","key":"2223_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/cts.13214","volume":"15","author":"S Maruyama","year":"2022","unstructured":"Maruyama\u00a0S, Visser\u00a0H, Ito\u00a0T et\u00a0al (2022) Phase\u00a0I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a\u00a0tissue-nonspecific alkaline phosphatase inhibitor. Clin Transl Sci 15(4):967\u2013980. https:\/\/doi.org\/10.1111\/cts.13214","journal-title":"Clin Transl Sci"},{"key":"2223_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23892-5","author":"K Soma","year":"2022","unstructured":"Soma\u00a0K, Watanabe\u00a0K, Izumi\u00a0M (2022) Anticalcification effects of DS-1211 in pseudoxanthoma elasticum mouse models and the role of tissue-nonspecific alkaline phosphatase in ABCC6-deficient ectopic calcification. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-23892-5","journal-title":"Sci Rep"},{"issue":"7","key":"2223_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/exd.14587","volume":"31","author":"IJ Jacobs","year":"2022","unstructured":"Jacobs\u00a0IJ, Cheng\u00a0Z, Ralph\u00a0D et\u00a0al (2022) INZ-701, a\u00a0recombinant ENPP1 enzyme, prevents ectopic calcification in an Abcc6\u2212\/\u2212 mouse model of pseudoxanthoma elasticum. Exp Dermatol 31(7):1095\u20131101. https:\/\/doi.org\/10.1111\/exd.14587","journal-title":"Exp Dermatol"},{"issue":"8","key":"2223_CR26","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jbmr.4315","volume":"36","author":"Z Cheng","year":"2021","unstructured":"Cheng\u00a0Z, O\u2019Brien\u00a0K, Howe\u00a0J et\u00a0al (2021) INZ-701 Prevents Ectopic Tissue Calcification and Restores Bone Architecture and Growth in ENPP1-Deficient Mice. J\u00a0Bone Miner Res 36(8):1594\u20131604. https:\/\/doi.org\/10.1002\/jbmr.4315","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2223_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/exd.14288","volume":"30","author":"IJ Jacobs","year":"2021","unstructured":"Jacobs\u00a0IJ, Li\u00a0D, Ivarsson\u00a0ME, Uitto\u00a0J, Li\u00a0Q (2021) A\u00a0phytic acid analogue INS-3001 prevents ectopic calcification in an Abcc6\u2212\/\u2212 mouse model of pseudoxanthoma elasticum. Exp Dermatol 30(6):853\u2013858. https:\/\/doi.org\/10.1111\/exd.14288","journal-title":"Exp Dermatol"},{"key":"2223_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14091-4","author":"AE Schantl","year":"2020","unstructured":"Schantl\u00a0AE, Verhulst\u00a0A, Neven\u00a0E et\u00a0al (2020) Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-14091-4","journal-title":"Nat Commun"},{"key":"2223_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054899","author":"B Murcia Casas","year":"2023","unstructured":"Murcia Casas\u00a0B, Carrillo Linares\u00a0JL, Baquero Aranda\u00a0I et\u00a0al (2023) Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A\u00a0Double-Blind, Randomized, Placebo-Controlled Crossover Trial. int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24054899","journal-title":"int J Mol Sci"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-025-02223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-025-02223-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-025-02223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:55:09Z","timestamp":1749729309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-025-02223-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2223"],"URL":"https:\/\/doi.org\/10.1007\/s00347-025-02223-9","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die Autoren geben folgende Interessenskonflikte an:\u00a0Jonathan Meinke: keine;\u00a0Kristin Raming: keine;\u00a0Maximilian Pfau: Daichii Sankyo, Inozyme, Bayer, Novartis, Angestellter bei F.\u00a0Hoffmann-La Roche bis 06\/2025;\u00a0Frank G.\u00a0Holz: Bayer, Novartis, Roche;\u00a0Kristina Pfau: Daichii Sankyo, Inozyme, Roche, Bayer, Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}